Legato Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$756K Hold
6,922
0.07% 377
2025
Q4
$561K Sell
6,922
-6,597
-49% -$568K 0.05% 513
2025
Q3
$1.18M Hold
13,519
0.13% 249
2025
Q2
$1.12M Sell
13,519
-7,898
-37% -$660K 0.13% 244
2025
Q1
$1.8M Sell
21,417
-1,761
-8% -$164K 0.24% 119
2024
Q4
$2.14M Buy
23,178
+476
+2% +$45.8K 0.28% 85
2024
Q3
$2.11M Sell
22,702
-2,634
-10% -$228K 0.26% 113
2024
Q2
$2.08M Buy
25,336
+6,028
+31% +$443K 0.28% 97
2024
Q1
$1.28M Hold
19,308
0.15% 221
2023
Q4
$1.1M Hold
19,308
0.14% 236
2023
Q3
$1.05M Sell
19,308
-7,760
-29% -$460K 0.15% 231
2023
Q2
$1.82M Buy
27,068
+1,281
+5% +$78.1K 0.25% 129
2023
Q1
$1.33M Hold
25,787
0.24% 136
2022
Q4
$1.19M Buy
+25,787
New +$1.21M 0.23% 145

Other funds holding LMAT

Legato Capital Management's LMAT Position: Q1 2026 in Review

Legato Capital Management held its LeMaitre Vascular (LMAT) position steady in Q1 2026 at 6,922 shares worth $756K. The position accounts for 0.07% of the portfolio, ranked #377.

Legato Capital Management first reported a position in LMAT in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.14M in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Legato Capital Management held 6,922 shares of LeMaitre Vascular worth $756K as of Q1 2026.
  • Legato Capital Management left its LeMaitre Vascular share count unchanged in Q1 2026.
  • LeMaitre Vascular made up 0.07% of Legato Capital Management's portfolio in Q1 2026, its #377 holding.
  • Legato Capital Management first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 14 quarters since.
  • Legato Capital Management's LeMaitre Vascular position peaked at $2.14M in Q4 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.